Metabomed LTD

Metabomed LTD is a drug discovery company in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. Metabomed focuses on the discovery of drugs that inhibit targets that form a synthetic lethal gene pair with metabolic genes inactivated in cancer cells. Metabomed operates out of MS Ventures Bioincubator in Yavne, Israel.

Team Members
more about
Jasper Bos
more about
Rom Eliaz
Latest News Entry
2016/04/04
Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing

Israeli cancer metabolism company Metabomed LTD. announced today that it has completed an extension of its Series A round from current and new investors bringing the total of its

all portfolio news